Qfor Quality Accreditation
ECCRT acquired the Qfor label after a process audit. The independent company "Management Information" audited ECCRT and made an elaborate report with attention for the structure, evolution, activities, services, experience, quality checks etc.
ECCRT received this accreditation for the third time, our label is now valid till 2022 !ECCRT Qfor certification
Recognition by TransCelerate BioPharma
Our ICH-GCP Training now also meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified by TransCelerate BioPharma as necessary to enable mutual recognition of GCP training among trial sponsors.
TransCelerate BioPharma Inc. is a non-profit organization dedicated to improving the health of people around the world by accelerating and simplifying the research and development (R&D) of innovative new therapies. The organizations' mission is to collaborate across the global R&D community to identify, prioritize, design and implement solutions designed to drive the efficient, effective and high quality delivery of innovative new therapies. TransCelerate evolved from discussions at various forums for executive R&D leadership to discuss relevant issues facing the industry and solutions for addressing common challenges. Founding members include AbbVie, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, the Roche Group, and Sanofi, and all have representation on the Board of Directors. Additional members include Astellas Pharma Inc., Biogen Idec, Braeburn Pharmaceuticals, Cubist Pharmaceuticals, EMD Serono, Inc. (a subsidiary of Merck KGaA, Darmstadt, Germany), Forest Research Institute (a subsidiary of Forest Laboratories, Inc.), Onyx Pharmaceuticals, Inc., an Amgen subsidiary, and UCB.
TransCelerate members have developed guidelines to give innovative drug companies the comfort necessary to recognize and rely on another member’s or Training Provider’s investigator site personnel GCP training meeting the identified Minimum Criteria. ECCRT's ICH-GCP training meets all these minimum criteria and is recognised by all the above companies as a training provider.
Recognition by the Government of Flanders
The Government of Flanders supports your training if you are an employee in a KMO (small to mid size company). The “European Centre for Clinical Research Training” (ECCRT) has been certified by the Flemish Government, this is a guarantee of quality. For each training at the ECCRT you pay as a KMO, the government makes 40% of the costs.
For the KMO-portefeuille, our Company Number is DV.O108281.
Certificates provided by ECCRT
Everyone who participates in our courses receives a Certificate of Attendance. In addition to this we offer a Certificate of Achievement for a growing selection of our courses, including the Clinical Research Training for Junior CRAs, Senior CRAs, CTAs and the Investigational Site Team course. More tests are being developed for other courses.
Participants receive these certificates after completing a comprehension test and achieving a test score of at least 70%. The test is composed of multiple choice and case study questions.
In case a training certificate is lost or a duplicate is required, click here to get more information on how to obtain a duplicate.